Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1on Dec 29, 2022 11:12am
223 Views
Post# 35195251

RE:RE:VIVO acquisition.

RE:RE:VIVO acquisition.For myself if the stock has been manipulated has some guys thinks it is because the strategie of both company didn't work, the results are just not there, the revenue are falling qrt after qrt. With the projections they made of the mergers works we are very far away of stock to a dollar. May be $0,15 if we are lucky for next year. The merger we are not even sure if it is going to happen and we have to wait 4 to 6 month before the confirmation, a pending situation like that is not any good for the investors we stay in the cloud, the picture for next year is not clear at all. The only think that is really clear for many of us is that we are still underater with our investment and there is no indication that we will be back in our money by the end of 2023. Expectation and hope are something but the reality with the stock price is very different.
Have everyone a very good year in 2023.
<< Previous
Bullboard Posts
Next >>